1. Home
  2. AVLN vs SHLS Comparison

AVLN vs SHLS Comparison

Compare AVLN & SHLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avalyn Pharma Inc. Common Stock

AVLN

Avalyn Pharma Inc. Common Stock

N/A

Current Price

$29.23

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Logo Shoals Technologies Group Inc.

SHLS

Shoals Technologies Group Inc.

HOLD

Current Price

$10.12

Market Cap

1.6B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVLN
SHLS
Founded
N/A
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.6B
IPO Year
2026
2020

Fundamental Metrics

Financial Performance
Metric
AVLN
SHLS
Price
$29.23
$10.12
Analyst Decision
Buy
Analyst Count
0
14
Target Price
N/A
$9.07
AVG Volume (30 Days)
545.5K
5.8M
Earning Date
N/A
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
42.86
EPS
N/A
N/A
Revenue
N/A
$475,331,000.00
Revenue This Year
N/A
$26.24
Revenue Next Year
N/A
$11.52
P/E Ratio
N/A
$41.63
Revenue Growth
N/A
19.07
52 Week Low
$27.33
$4.44
52 Week High
$33.32
$13.18

Technical Indicators

Market Signals
Indicator
AVLN
SHLS
Relative Strength Index (RSI) 35.88 50.44
Support Level $27.37 $8.10
Resistance Level $33.32 $11.27
Average True Range (ATR) 2.54 0.82
MACD -0.26 -0.03
Stochastic Oscillator 31.72 53.95

Price Performance

Historical Comparison
AVLN
SHLS

About AVLN Avalyn Pharma Inc. Common Stock

Avalyn Pharma Inc is a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs). Its current pipeline is focused on treating pulmonary fibrosis, a life-threatening disease with a median survival of three to five years, which is a significantly shorter prognosis than that observed for many forms of cancer. Its flagship programs include AP01 and AP02, which are inhaled formulations of pirfenidone and nintedanib being developed for conditions such as progressive pulmonary fibrosis and idiopathic pulmonary fibrosis. The company has one operating and reportable segment, which is the business of developing and commercializing targeted therapies for rare lung diseases.

About SHLS Shoals Technologies Group Inc.

Shoals Technologies Group is a provider of electrical balance of system solutions for solar energy projects, primarily in the United States. EBOS encompasses components that are necessary to carry electric current produced by solar panels to an inverter. The products are sold principally to engineering, procurement, and construction firms that build solar energy projects.

Share on Social Networks: